EAHAD Gene Therapy Trials Database

The EAHAD-GTD is a user-friendly, publicly accessible database gathering the latest gene therapy results focusing on safety issues, reporting only the published cases. It is designed to serve physicians and researchers actively involved in gene therapy research and clinical practice to connect them with the latest insights into ongoing and completed clinical trials, offering a comprehensive understanding of recent advancements in gene therapy for haemophilia.

The EAHAD-GTD can also be used by people with haemophilia who are considering gene therapy to see the primary data which they can discuss with their clinical teams.

The EAHAD-GTD is divided into three sections: "General Study Information", "Efficacy details", and "Safety details", making information retrieval efficient and user-friendly.

ACCESS THE DATABASE →

Last updated: 01/08/2024

Total number of trials
11
Haemophilia A
11
Haemophilia B
Total number of patient exposures
202
Haemophilia A
135
Haemophilia B
Number of malignancies post gene therapy
2
Haemophilia A
2
Haemophilia B
Number of thrombosis post gene therapy
0
Haemophilia A
1
Haemophilia B